Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Workshop Session III November 7, 2011 Richard Gliklich, MD, President & CEO, Outcome, Cambridge, MA, USA; Newell McElwee, PharmD, MSPH, Exec Director,
Taken from presentations given at the 2013 National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Conference, London 9–10 October.
Designing Better Comparative Effectiveness Research
Stakeholder –defined research Designing Studies that reflect the perspectives of Patients, clinicians and Payers
